Viatris (VTRS) Invested Capital (2019 - 2026)
Viatris' (VTRS) quarterly Invested Capital came in at $1.9 billion in Q1 2026, up 15.1% year-on-year from $1.7 billion in Q1 2025, and little changed quarter-over-quarter from $1.9 billion in Q4 2025.
Viatris (VTRS) Invested Capital (2019 - 2026) Analysis & Trends
Viatris' Invested Capital history runs 8 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- On a quarterly basis, Invested Capital rose 15.1% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $7.5 billion, a 49.19% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 322116.67% from the prior year.
- Invested Capital held at $1.9 billion in Q1 2026 per VTRS's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Invested Capital topped out at $2.0 billion in Q3 2025 and bottomed at $100000.0 in Q3 2023.
- The 5-year median for Invested Capital is $1.7 billion (2024), against an average of $1.2 billion.
- Across the five-year window, Invested Capital slumped 99.99% in 2023 and surged 1673800.0% in 2024, its largest moves.
- Year by year, Invested Capital stood at $1.3 billion in 2022, then soared by 53.66% to $1.9 billion in 2023, then tumbled by 99.97% to $600000.0 in 2024, then soared by 322116.67% to $1.9 billion in 2025, then dropped by 0.29% to $1.9 billion in 2026.
- Per Business Quant, the three latest VTRS Invested Capital figures stand at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 23.20 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 755.00 Mn |
| Jun 30, 2022 | 768.20 Mn |
| Mar 31, 2022 | 655.40 Mn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | 1.88 Bn |
| Jun 30, 2021 | 1.30 Bn |